Claraphi Advisory Network, LLC Natera, Inc. Transaction History

Claraphi Advisory Network, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$100.17 - $126.36 $506,760 - $639,255	-5,059 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$86.05 - $119.72 $428,873 - $596,684	-4,984 Reduced 49.63%	5,059 $574,000
Q1 2021 Apr 30, 2021	SELL	$91.47 - $124.36 $6,037 - $8,207	-66 Reduced 0.65%	10,043 $1.02 Million
Q4 2020 Feb 05, 2021	BUY	$66.66 - $111.74 $440,355 - $738,154	6,606 Added 188.58%	10,109 $1.01 Million
Q3 2020 Nov 13, 2020	BUY	$45.89 - $72.67 $160,752 - $254,563	3,503 New	3,503 $253,000

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Claraphi Advisory Network, LLC with notifications on news.